Prezista - patient leaflet, side effects, dosage

1. What PREZISTA is and what it is used for

What is PREZISTA?

PREZISTA contains the active substance darunavir. PREZISTA is an antiretroviral medicine used in the treatment of Human Immunodeficiency Virus (HIV) infection. It belongs to a group of medicines called protease inhibitors. PREZISTA works by reducing the amount of HIV in your body. This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection.

What it is used for?

PREZISTA is used to treat HIV infected adults as well as HIV infected children of 3 years of age and above, and at least 15 kilogram body weight (see

How to take PREZISTA)

.

PREZISTA must be taken in combination with a low dose of cobicistat or ritonavir and other anti-HIV medicines. Your doctor will discuss with you which combination of medicines is best for you.

2. What you need to know before you take PREZISTA

Do not take PREZISTA

• – if you are allergic to darunavir or any of the other ingredients of this medicine (listed in section

• 6) or to cobicistat or ritonavir.

• – if you have severe liver problems. Ask your doctor if you are unsure about the severity of your

liver disease. Some additional tests might be necessary.

Tell your doctor about all medicines you take including medicines taken orally, inhaled, injected or applied to the skin.

Do not combine PREZISTA with any of the following medicines

If you are taking any of these, ask your doctor about switching to another medicine.

Medicine	Purpose of the medicine
Avanafil	to treat erectile dysfunction
Astemizole or terfenadine	to treat allergy symptoms
Triazolam and oral (taken by mouth) midazolam	to help you sleep and/or relieve anxiety

Cisapride	to treat some stomach conditions
Colchicine (if you have kidney and/or liver problems)	to treat gout or familial Mediterranean fever
Lurasidone, pimozide, quetiapine or sertindole	to treat psychiatric conditions
Ergot alkaloids like ergotamine , dihydroergotamine , ergometrine and methylergonovine	to treat migraine headaches
Amiodarone, bepridil, dronedarone, ivabradine, quinidine, ranolazine	to treat certain heart disorders e.g. abnormal heart beat
Lovastatin , simvastatin and lomitapide	to lower cholesterol levels
Rifampicin	to treat some infections such as tuberculosis
The combination product lopinavir/rito­navir	this anti-HIV medicine belongs to the same class as PREZISTA
Elbasvir/grazo­previr	to treat hepatitis C infection
Alfuzosin	to treat enlarged prostate
Sildenafil	to treat high blood pressure in the pulmonary circulation
Dabigatran , ticagrelor	to help stop the clumping of platelets in the treatment of patients with a history of a heart attack
Naloxegol	to treat opioid induced constipation
Dapoxetine	to treat premature ejaculation
Domperidone	to treat nausea and vomiting

Do not combine PREZISTA with products that contain St John’s Wort (Hypericum perforatum).

Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking PREZISTA.

PREZISTA is not a cure for HIV infection. You can still pass on HIV when taking this medicine, although the risk is lowered by effective antiretroviral therapy. Discuss with your physician the precautions needed to avoid infecting other people.

People taking PREZISTA may still develop infections or other illnesses associated with HIV infection. You must keep in regular contact with your doctor.

People taking PREZISTA may develop a skin rash. Infrequently a rash may become severe or potentially life-threatening. Please contact your doctor whenever you develop a rash.

In patients taking PREZISTA and raltegravir (for HIV infection), rashes (generally mild or moderate) may occur more frequently than in patients taking either medicine separately.

Tell your doctor about your situation BEFORE and DURING your treatment

Make sure that you check the following points and tell your doctor if any of these apply to you.

• – Tell your doctor if you have had problems with your liver before, including hepatitis B or C

infection. Your doctor may evaluate how severe your liver disease is before deciding if you can take PREZISTA.

• – Tell your doctor if you have diabetes. PREZISTA might increase sugar levels in the blood.

• – Tell your doctor immediately if you notice any symptoms of infection (for example enlarged

lymph nodes and fever). In some patients with advanced HIV infection and a history of opportunistic infection, signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.

• – In addition to the opportunistic infections, autoimmune disorders (a condition that occurs when

the immune system attacks healthy body tissue) may also occur after you start taking medicines for the treatment of your HIV infection. Autoimmune disorders may occur many months after the start of treatment. If you notice any symptoms of infection or other symptoms such as muscle weakness, weakness beginning in the hands and feet and moving up towards the trunk of the body, palpitations, tremor or hyperactivity, please inform your doctor immediately to seek necessary treatment.

• – Tell your doctor if you have haemophilia. PREZISTA might increase the risk of bleeding.

• – Tell your doctor if you are allergic to sulphonamides (e.g. used to treat certain infections).

• – Tell your doctor if you notice any musculoskeletal problems. Some patients taking

combination antiretroviral therapy may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone). The length of combination antiretroviral therapy, corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index, among others, may be some of the many risk factors for developing this disease. Signs of osteonecrosis are joint stiffness, aches and pains (especially of the hip, knee and shoulder) and difficulty in movement. If you notice any of these symptoms please inform your doctor.

Elderly

PREZISTA has only been used in limited numbers of patients 65 years or older. If you belong to this age group, please discuss with your doctor if you can use PREZISTA.

Children

PREZISTA is not for use in children younger than 3 years of age or weighing less than 15 kilograms.

Other medicines and PREZISTA

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines.

There are some medicines that you must not combine with PREZISTA. These are mentioned above under the heading ‘Do not combine PREZISTA with any of the following medicines:’

In most cases, PREZISTA can be combined with anti-HIV medicines belonging to another class [e.g. NRTIs (nucleoside reverse transcriptase inhibitors), NNRTIs (non-nucleoside reverse transcriptase inhibitors), CCR5 antagonists and FIs (fusion inhibitors)]. PREZISTA with cobicistat or ritonavir has not been tested with all PIs (protease inhibitors) and must not be used with other HIV PIs. In some cases dosage of other medicines might need to be changed. Therefore always tell your doctor if you take other anti-HIV medicines and follow your doctor’s instruc­tion carefully on which medicines can be combined.

The effects of PREZISTA might be reduced if you take any of the following products. Tell your doctor if you take:

• - Phenobarbital, phenytoin (to prevent seizures)

• - Dexamethasone (corticosteroid)

• - Efavirenz (HIV infection)

• - Rifapentine, rifabutin (medicines to treat some infections such as tuberculosis)

• - Saquinavir (HIV infection).

The effects of other medicines might be influenced if you take PREZISTA. Tell your doctor if you take:

• - Amlodipine, diltiazem, disopyramide, carvedilol, felodipine, flecainide, lidocaine, metoprolol,

mexiletine, nifedipine, nicardipine , propafenone , timolol, verapamil (for heart disease) as the therapeutic effect or side effects of these medicines may be increased.

• - Apixaban, edoxaban, rivaroxaban, warfarin, clopidogrel (to reduce clotting of the blood) as

their therapeutic effect or side effects may be altered; your doctor may have to check your blood.

• – Oestrogen-based hormonal contraceptives and hormonal replacement therapy. PREZISTA

might reduce its effectiveness. When used for birth control, alternative methods of non-hormonal contraception are recommended.

• - Ethinylestradi­ol/drospireno­ne. PREZISTA might increase the risk for elevated potassium levels

by drospirenone.

• - Atorvastatin, pravastatin, rosuvastatin (to lower cholesterol levels). The risk of muscle damage

might be increased. Your doctor will evaluate which cholesterol lowering regimen is best for your specific situation.

• - Clarithromycin (antibiotic)

• - Ciclosporin, everolimus, tacrolimus, sirolimus (for dampening down your immune system) as

the therapeutic effect or side effects of these medicines might be increased. Your doctor might want to do some additional tests.

• - Corticosteroids including betamethasone, budesonide, fluticasone, mometasone, prednisone,

triamcinolone. These medicines are used to treat allergies, asthma, inflammatory bowel diseases, inflammatory conditions of the skin, eyes, joints and muscles and other inflammatory conditions. These medicines are generally taken orally, inhaled, injected or applied to the skin. If alternatives cannot be used, its use should only take place after medical evaluation and under close monitoring by your doctor for corticosteroid side effects.

• - Buprenorphine/na­loxone (medicines to treat opioid dependence)

• - Salmeterol (medicine to treat asthma)

• - Artemether/lu­mefantrine (a combination medicine to treat malaria)

• - Dasatinib, everolimus, irinotecan, nilotinib, vinblastine, vincristine (to treat cancer)

• - Sildenafil, tadalafil, vardenafil (for erectile dysfunction or to treat a heart and lung disorder

called pulmonary arterial hypertension)

• - Glecaprevir/pi­brentasvir (to treat hepatitis C infection)

• - Fentanyl, oxycodone, tramadol (to treat pain)

• - Fesoterodine , solifenacin (to treat urologic disorders).

The dosage of other medicines might need to be changed since either their own or PREZISTA’s the­rapeutic effect or side effects may be influenced when combined.

Tell your doctor if you take:

• - Alfentanil (injectable strong and short-acting painkiller that is used for surgical procedures)

• - Digoxin (to treat certain heart disorders)

• - Clarithromycin (antibiotic)

• - Itraconazole, isavuconazole, fluconazole, posaconazole, clotrimazole (to treat fungal

infections). Voriconazole should only be taken after medical evaluation.

• - Rifabutin (against bacterial infections)

• - Sildenafil, vardenafil, tadalafil (for erectile dysfunction or high blood pressure in the pulmonary

circulation)

• - Amitriptyline, desipramine, imipramine, nortriptyline, paroxetine, sertraline, trazodone (to treat

depression and anxiety)

• - Maraviroc (to treat HIV infection)

• - Methadone (to treat opiate dependence)

• - Carbamazepine, clonazepam (to prevent seizures or to treat certain types of nerve pain)

• - Colchicine (to treat gout or familial Mediterranean fe­ver)

• - Bosentan (to treat high blood pressure in the pulmonary circulation)

• - Buspirone, clorazepate, diazepam, estazolam, flurazepam, midazolam when used as injection,

zolpidem (sedative agents)

• - Perphenazine, risperidone, thioridazine (to treat psychiatric conditions)

• - Metformin (to treat type 2 diabetes).

This is not a complete list of medicines. Tell your healthcare provider about all medicines that you are taking.

PREZISTA with food and drink

See section 3 ‘How to take PREZISTA.’

Pregnancy and breast-feeding

Tell your doctor immediately if you are pregnant, planning to become pregnant or if you are breast-feeding. Pregnant or breast-feeding mothers should not take PREZISTA with ritonavir unless specifically directed by the doctor. Pregnant or breast-feeding mothers should not take PREZISTA with cobicistat.

It is recommended that HIV infected women must not breast-feed their infants because of both the possibility of your baby becoming infected with HIV through your breast milk and because of the unknown effects of the medicine on your baby.

Driving and using machines

Do not operate machines or drive if you feel dizzy after taking PREZISTA.

PREZISTA oral suspension contains sodium methyl parahydroxyben­zoate. This ingredient may cause allergic reactions (sometimes delayed).

PREZISTA contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per ml, that is to say essentially ‘sodium-free’.

3. How to take PREZISTA

Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure.

Even if you feel better, do not stop taking PREZISTA and cobicistat or ritonavir without talking to your doctor.

After therapy has been initiated, the dose or dosage form must not be changed or therapy must not be stopped without instruction of the doctor.

Dose for children of 3 years of age and above, weighing at least 15 kilograms who have not taken antiretroviral medicines before (your child’s doctor will determine this)

The doctor will work out the right once daily dose based on the weight and age of the child (see table below). This dose must not exceed the recommended adult dose, which is 800 milligram PREZISTA together with 150 milligram cobicistat or 100 milligram ritonavir once a day.

The doctor will inform you on how much PREZISTA oral suspension and how much cobicistat (tablet) or ritonavir (capsules, tablets or solution) the child must take.

Weight	One PREZISTA dose is	One ritonavir a dose is	One cobicistat dose is
between 15 and 30 kilograms	600 milligram (6 milliliter)	100 milligram (1.2 milliliter)	Do not take
between 30 and 40 kilograms	675 milligram (6.8 milliliter)	100 milligram (1.2 milliliter)	Do not take
more than 40 kilograms	800 milligram (8 milliliter)	100 milligram (1.2 milliliter)	150 milligramb

aritonavir oral solution: 80 milligram per milliliter bthe child must be 12 years old or older

The child must take PREZISTA every day and always in combination with 150 milligram cobicistat or 100 milligram of ritonavir and with food. PREZISTA cannot work properly without cobicistat or ritonavir and food. The child must eat a meal or a snack within 30 minutes prior to taking PREZISTA and either cobicistat or ritonavir. The type of food is not important.

Your child’s doctor will determine if your child should take PREZISTA with either cobicistat or ritonavir.

Dose for children of 3 years of age and above, weighing at least 15 kilograms who have taken antiretroviral medicines before (your child’s doctor will determine this)

The doctor will work out the right dose based on the weight and age of the child (see table below). The doctor will determine if once daily dosing or twice daily dosing is appropriate for the child. This dose must not exceed the recommended adult dose, which is 600 milligram PREZISTA together with 100 milligram ritonavir two times per day or 800 milligram PREZISTA together with 150 milligram cobicistat or 100 milligram ritonavir once a day.

The doctor will inform you on how much PREZISTA oral suspension and how much cobicistat (tablet) or ritonavir (capsules, tablets or solution) the child must take.

Twice daily dosing

Weight	One PREZISTA dose is	One ritonavir a dose is
between 15 and 30 kilograms	380 milligram (3.8 milliliter)	50 milligram (0.6 milliliter)
between 30 and 40 kilograms	460 milligram (4.6 milliliter)	60 milligram (0.8 milliliter)
more than 40 kilograms	600 milligram (6 milliliter)	100 milligram (1.2 milliliter)

a ritonavir oral solution: 80 milligram per milliliter

Once daily dosing

Weight	One PREZISTA dose is	One ritonavir a dose is	One cobicistat dose is
between 15 and 30 kilograms	600 milligram (6 milliliter)	100 milligram (1.2 milliliter)	Do not take
between 30 and 40 kilograms	675 milligram (6.8 milliliter)	100 milligram (1.2 milliliter)	Do not take
more than 40 kilograms	800 milligram (8 milliliter)	100 milligram (1.2 milliliter)	150 milligramb

aritonavir oral solution: 80 milligram per milliliter bthe child must be 12 years old or older

Instructions for children

• – The child must take PREZISTA always together with cobicistat or ritonavir. PREZISTA cannot

work properly without cobicistat or ritonavir.

• – The child must take the appropriate doses of PREZISTA and ritonavir two times per day or once

a day or PREZISTA and cobicistat once a day. If prescribed PREZISTA twice daily the child must take one dose in the morning, and one dose in the evening. Your child’s doctor will determine the appropriate dosing regimen for your child.

• – The child must take PREZISTA with food. PREZISTA cannot work properly without food. The

type of food is not important.

Dose for adults who have not taken antiretroviral medicines before (your doctor will determine this)

The usual dose of PREZISTA is 800 milligram once daily.

You must take PREZISTA every day and always in combination with 150 milligram of cobicistat or 100 milligram of ritonavir and with food. PREZISTA cannot work properly without cobicistat or ritonavir and food. You must eat a meal or a snack within 30 minutes prior to taking your PREZISTA and cobicistat or ritonavir. The type of food is not important. Even if you feel better, do not stop taking PREZISTA and cobicistat or ritonavir without talking to your doctor.

Dose for adults who have taken antiretroviral medicines before (your doctor will determine this) The dose is either:

• – 600 milligram PREZISTA together with 100 milligram ritonavir twice daily.

OR

• – 800 milligram PREZISTA together with 150 milligram cobicistat or 100 milligram ritonavir

once daily.

Please discuss with your doctor which dose is right for you.

Instructions for adults

• – Take PREZISTA always together with cobicistat or ritonavir. PREZISTA cannot work properly

without cobicistat or ritonavir.

• – Take PREZISTA with food. PREZISTA cannot work properly without food. The type of food is

not important.

Instructions for use

Use the dosing pipette supplied with the pack to measure your dose accurately:

• 1. Shake the bottle well before each use.

• 2. Open the bottle of PREZISTA oral suspension by pushing downward on the cap and twisting it counter-clockwise.

• 3. Insert the supplied oral dosing pipette all the way into the bottle.

• 4. Pull the plunger until the top of the barrel meets the line that matches the dose prescribed by your healthcare provider.

• 5. Take the dose of PREZISTA. Place the tip of the oral dosing pipette in the mouth. Press on the plunger of the pipette towards the mouth, then swallow.

• 6. Close the bottle with the cap after use, and store PREZISTA oral suspension as directed in section 5 below.

• 7. Remove the plunger from the barrel of the pipette, rinse both with water and allow to air dry after each use.

• 8. Put the oral dosing pipette back together after air drying and store with the PREZISTA bottle.

Do not use the dosing pipette for any other medicines.

If you take more PREZISTA than you should

Contact your doctor, pharmacist or nurse immediately.

If you forget to take PREZISTA

If you take PREZISTA two times a day and if you notice within 6 hours , you must take the oral suspension immediately. Always take with ritonavir and food. If you notice after 6 hours , then skip the intake and take the next doses as usual. Do not take a double dose to make up for a forgotten dose.

If you take PREZISTA once a day and if you notice within 12 hours , you must take the oral suspension immediately. Always take with cobicistat or ritonavir and food. If you notice after 12 hours , then skip the intake and take the next doses as usual. Do not take a double dose to make up for a forgotten dose.

If you vomit after taking PREZISTA and cobicistat or ritonavir

If you vomit within 4 hours of taking the medicine, another dose of PREZISTA and cobicistat or ritonavir should be taken with food as soon as possible. If you vomit more than 4 hours after taking the medicine, then you do not need to take another dose of PREZISTA and cobicistat or ritonavir until the next regularly scheduled time.

Contact your doctor if you are uncertain about what to do if you miss a dose or vomit.

Do not stop taking PREZISTA without talking to your doctor first

Anti-HIV medicines may make you feel better. Even when you feel better, do not stop taking PREZISTA. Talk to your doctor first.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

During HIV therapy there may be an increase in weight and in levels of blood lipids and glucose. This is partly linked to restored health and life style, and in the case of blood lipids sometimes to the HIV medicines themselves. Your doctor will test for these changes.

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor if you develop any of the following side effects

Liver problems that may occasionally be severe have been reported. Your doctor should do blood tests before you start PREZISTA. If you have chronic hepatitis B or C infection, your doctor should check your blood tests more often because you have an increased chance of developing liver problems. Talk to your doctor about the signs and symptoms of liver problems. These may include yellowing of your skin or whites of your eyes, dark (tea coloured) urine, pale coloured stools (bowel movements), nausea, vomiting, loss of appetite, or pain, aching, or pain and discomfort on your right side below your ribs.

Skin rash (more often when used in combination with raltegravir), itching. The rash is usually mild to moderate. A skin rash might also be a symptom of a rare severe situation. It is important to talk to your doctor if you develop a rash. Your doctor will advise you how to deal with your symptoms or whether PREZISTA must be stopped.

Other severe side effects were diabetes (common) and inflammation of the pancreas (uncommon).

Very common side effects (may affect more than 1 in 10 people) – diarrhoea.

Common side effects (may affect up to 1 in 10 people)

• – vomiting, nausea, abdominal pain or distension, dyspepsia, flatulence

• – headache, tiredness, dizziness, drowsiness, numbness, tingling or pain in hands or feet, loss of

strength, difficulty falling asleep.

Uncommon side effects (may affect up to 1 in 100 people)

• – chest pain, changes in electrocardiogram, rapid heart beating

• – decreased or abnormal skin sensibility, pins and needles, attention disturbance, loss of memory,

problems with your balance

• – difficulty breathing, cough, nosebleed, throat irritation

• – inflammation of the stomach or mouth, heartburn, retching, dry mouth, discomfort of the

abdomen, constipation, belching

• – kidney failure, kidney stones, difficult discharge of urine, frequent or excessive passage of

urine, sometimes at night

• – urticaria, severe swelling of the skin and other tissues (most often the lips or the eyes), eczema,

excessive sweating, night sweats, hair loss, acne, scaly skin, colouration of nails

• – muscle pain, muscle cramps or weakness, pain in extremity, osteoporosis

• – slowing down of the thyroid gland function. This can be seen in a blood test.

• – high blood pressure, flushing

• – red or dry eyes

• – fever, swelling of lower limbs due to fluids, malaise, irritability, pain

• – symptoms of infection, herpes simplex

• – erectile dysfunction, enlargement of breasts

• – sleeping problems, sleepiness, depression, anxiety, abnormal dreams, decrease in sexual drive

Rare side effects (may affect up to 1 in 1,000 people)

• – a reaction called DRESS [severe rash, which may be accompanied by fever, fatigue, swelling of

the face or lymph glands, increase of eosinophils (type of white blood cells), effects on liver, kidney or lung]

• – heart attack, slow heart beating, palpitations

• – visual disturbance

• – chills, feeling abnormal

• – a feeling of confusion or disorientation, altered mood, restlessness

• – fainting, epileptic fits, changes or loss of taste

• – mouth sores, vomiting blood, inflammation of the lips, dry lips, coated tongue

• – running nose

• – skin lesions, dry skin

• – stiffness of muscles or joints, joint pain with or without inflammation

• – changes in some values of your blood cells or chemistry. These can be seen in the results of

blood and/or urine tests. Your doctor will explain these to you. Examples are: increase in some white blood cells.

Some side effects are typical for anti-HIV medicines in the same family as PREZISTA. These are:

• – muscle pain, tenderness or weakness. On rare occasions, these muscle disorders have been

serious.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store PREZISTA

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the bottle after EXP. The expiry date refers to the last day of that month.

Do not store above 30°C.

Do not refrigerate or freeze. Avoid exposure to excessive heat.

Store in the original container.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away any medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What PREZISTA contains

• – The active substance is darunavir. Each milliliter contains 100 milligram of darunavir (as

ethanolate).

• – The other ingredients are hydroxypropyl cellulose, microcrystalline cellulose and carmellose

What PREZISTA looks like and contents of the pack

White to off-white opaque oral suspension. Provided in a 200 ml amber glass bottle with polypropylene child resistant closure and a 6 ml low density polyethylene (LDPE) oral dosing pipette with 0.2 ml gradations. The bottle neck is filled with a low density polyethylene (LDPE) insert that accommodates the dosing pipette. Do not use the oral dosing pipette for any other medicines.

PREZISTA is also available as 75 milligram, 150 milligram, 400 milligram, 600 milligram and 800 milligram film-coated tablets.

Marketing Authorisation Holder

Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, Belgium

Manufacturer

Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

België/Belgiqu­e/Belgien Janssen-Cilag NV Tel/Tél: +32 14 64 94 11	Lietuva UAB „JOHNSON & JOHNSON“ Tel: +370 5 278 68 88
Efc^rapufl „^>KOHCbH & ^>KOHCbH Ebirapub' EOOfl Ten.: +359 2 489 94 00	Luxembourg/Lu­xemburg Janssen-Cilag NV Tél/Tel: +32 14 64 94 11
Česká republika Janssen-Cilag s.r.o. Tel: +420 227 012 227	Magyarország Janssen-Cilag Kft. Tel.: +36 1 884 2858
Danmark Janssen-Cilag A/S Tlf: +45 4594 8282	Malta AM MANGION LTD Tel: +356 2397 6000
Deutschland Janssen-Cilag GmbH Tel: +49 2137 955 955	Nederland Janssen-Cilag B.V. Tel: +31 76 711 1111
Eesti UAB „JOHNSON & JOHNSON“ Eesti filiaal Tel: +372 617 7410	Norge Janssen-Cilag AS Tlf: +47 24 12 65 00
EXÁáóa Janssen-Cilag «'DappaKsuuKi] A.E.B.E. Tql: +30 210 80 90 000	Österreich Janssen-Cilag Pharma GmbH Tel: +43 1 610 300
España Janssen-Cilag, S.A. Tel: +34 91 722 81 00	Polska Janssen-Cilag Polska Sp. z o.o. Tel.: +48 22 237 60 00
France Janssen-Cilag Tél: 0 800 25 50 75 / +33 1 55 00 40 03	Portugal Janssen-Cilag Farmacêutica, Lda. Tel: +351 214 368 600

Hrvatska Johnson & Johnson S.E. d.o.o. Tel: +385 1 6610 700	România Johnson & Johnson Româ nia SRL Tel: +40 21 207 1800
Ireland Janssen Sciences Ireland UC Tel: +353 1 800 709 122	Slovenija Johnson & Johnson d.o.o. Tel: +386 1 401 18 00
Ísland Janssen-Cilag AB c/o Vistor hf. Sími: +354 535 7000	Slovenská republika Johnson & Johnson, s.r.o. Tel: +421 232 408 400
Italia Janssen-Cilag SpA Tel: 800.688.777 / +39 02 2510 1	Suomi/Finland Janssen-Cilag Oy Puh/Tel: +358 207 531 300
Kùnpoç Bapváßaç XaTZnnavaY^ç Ató Tql: +357 22 207 700	Sverige Janssen-Cilag AB Tfn: +46 8 626 50 00
Latvija UAB „JOHNSON & JOHNSON“ filiäle Latvijä Tel: +371 678 93561	United Kingdom (Northern Ireland) Janssen Sciences Ireland UC Tel: +44 1 494 567 444

This leaflet was last revised in {MM/YYYY}.

Detailed information on this medicine is available on the European Medicines Agency web site:.